Abstract
Synthesis and biological evaluation of a novel series of substituted pentacyclic triterpene derivatives as potential PPARγ agoinsts and glycogen phosphorylase inhibitors have been described. Compounds 11 and 17 showed potent PPARγ agonistic activity and activated the transcription activity of PPARγ in a dose-dependent manner. On the other hand, eleven compounds exhibited moderate inhibitory activity against rabbit muscle glycogen phosphorylase a (RMGPa), and triterpene 10 was the best one. Structure-activity relationship (SAR) is also discussed.
Keywords: Diabetes, Glycogen phosphorylase inhibitors, Oleanolic acid, PPARγ agonists, Pentacyclic triterpene, Ursolic acid
Medicinal Chemistry
Title:Synthesis and Biological Evaluation of Novel Pentacyclic Triterpene Derivatives as Potential PPARγ Agonists
Volume: 9 Issue: 1
Author(s): Liying Zhang, Jizhe Dong, Jun Liu, Luyong Zhang, Lingyi Kong, Hequan Yao and Hongbin Sun
Affiliation:
Keywords: Diabetes, Glycogen phosphorylase inhibitors, Oleanolic acid, PPARγ agonists, Pentacyclic triterpene, Ursolic acid
Abstract: Synthesis and biological evaluation of a novel series of substituted pentacyclic triterpene derivatives as potential PPARγ agoinsts and glycogen phosphorylase inhibitors have been described. Compounds 11 and 17 showed potent PPARγ agonistic activity and activated the transcription activity of PPARγ in a dose-dependent manner. On the other hand, eleven compounds exhibited moderate inhibitory activity against rabbit muscle glycogen phosphorylase a (RMGPa), and triterpene 10 was the best one. Structure-activity relationship (SAR) is also discussed.
Export Options
About this article
Cite this article as:
Zhang Liying, Dong Jizhe, Liu Jun, Zhang Luyong, Kong Lingyi, Yao Hequan and Sun Hongbin, Synthesis and Biological Evaluation of Novel Pentacyclic Triterpene Derivatives as Potential PPARγ Agonists, Medicinal Chemistry 2013; 9 (1) . https://dx.doi.org/10.2174/1573406411309010118
DOI https://dx.doi.org/10.2174/1573406411309010118 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ligand and Structure Based Models for the Identification of Beta 2 Adrenergic Receptor Antagonists
Current Computer-Aided Drug Design The Design of Drug Candidate Molecules as Selective Inhibitors of Therapeutically Relevant Protein Kinases
Current Medicinal Chemistry Recent Developments in the Virology and Antiviral Research of Severe Acute Respiratory Syndrome Coronavirus
Infectious Disorders - Drug Targets Synthesis and Computational Studies on Aryloxypropyl Piperazine Derivatives as Potential Atypical Antipsychotic Agents
Letters in Drug Design & Discovery Impacts and Consequences of COVID-19 Epidemic on Global Economy
Coronaviruses Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker
Infectious Disorders - Drug Targets Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight
Current Pharmaceutical Biotechnology Hypertension in Pregnancy: A Review of Current Guidelines
Current Women`s Health Reviews Safety Considerations Associated with Development and Clinical Application of Lentiviral Vector Systems for Gene Transfer
Current Genomics Serum Endocan, Neuron-Specific Enolase and Ischemia-Modified Albumin Levels in Newborns with Partial Blood Exchange Transfusion
Combinatorial Chemistry & High Throughput Screening Bioactive Chromone Derivatives – Structural Diversity
Current Bioactive Compounds 2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 2
Medicinal Chemistry Ligand-Based Approaches in Virtual Screening
Current Computer-Aided Drug Design Nitric Oxide and Disorders of the Erythrocyte: Emerging Roles and Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design
Current Medicinal Chemistry Computer-Assisted Methods in Chemical Toxicity Prediction
Mini-Reviews in Medicinal Chemistry Synthesis of Imidazo[1,2-b]pyridazine Comprised Piperazine, Morpholine Derivatives as Potent Antimycobacterial Agents with In Vivo Locomotor Activity
Anti-Infective Agents Meet Our Editorial Board Member
Medicinal Chemistry A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far?
Infectious Disorders - Drug Targets IgE, Allergic Diseases, and Omalizumab
Current Pharmaceutical Design